fbpx

Life+News The Official News Portal of Independent Television Network Ltd

Liquid aspirin is shrinking brain tumours in mice

ITN News Editor
By ITN News Editor August 7, 2019 12:15

Liquid aspirin is shrinking brain tumours in mice

A new drug containing a liquid form of aspirin could in future help treat some of the most aggressive brain cancers, according to researchers at the Brain Tumour Research Centre at the University of Portsmouth. The team, led by molecular biologist Dr. Richard Hill, showed promising early stage results testing tumours in mice with the drug IP1867B. It combines reformulated aspirin with triacetin and saccharin in a soluble form. Brain tumours are among the most difficult cancers to treat, with low survival rates and according to Dr. Hill, is an area where new treatments are desperately needed. IP1867B has shown to reduce the size of adult high-grade glioma brain tumours in mice, while reducing the stomach problems associated with conventional aspirin tablets, the tests have shown.

ITN News Editor
By ITN News Editor August 7, 2019 12:15

BUSINESS NEWS- VIEW ALL

SPORTS NEWS- VIEW ALL

ENTERTAINMENT- VIEW ALL